Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-06-24 @ 10:59 PM
Study NCT ID:
NCT04239092
Status:
TERMINATED
Last Update Posted:
2025-07-17
First Post:
2020-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
9-ING-41 in Pediatric Patients With Refractory Malignancies.
Sponsor:
Actuate Therapeutics Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1902
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None